Comment on Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540
With great interest, we have read the paper by Hosmann et al. [...]
Guardado en:
Autores principales: | Walter Stummer, Christian Thomas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bd2a7d4d894b4bafa5232ff80590209e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. <i>Cancers</i> 2021, <i>13</i>, 2540”
por: Arthur Hosmann, et al.
Publicado: (2021) -
<i>TP53</i> Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy
por: Humaira Noor, et al.
Publicado: (2021) -
Graded I-second submodules
por: Bataineh Malik, et al.
Publicado: (2021) -
<i>PODNL1</i> Methylation Serves as a Prognostic Biomarker and Associates with Immune Cell Infiltration and Immune Checkpoint Blockade Response in Lower-Grade Glioma
por: Humaira Noor, et al.
Publicado: (2021) -
Quantitative SPECT/CT for differentiating between enchondroma and grade I chondrosarcoma
por: Woo Hee Choi, et al.
Publicado: (2020)